RedHill Biopharma Ltd. ADR (RDHL)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 70
-0.03
-3.5568%
$
2.32M Market Cap
- P/E Ratio
- Div Yield
70,000 Volume
- Eps
$ 0.73
Previous Close Want to track RDHL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
RedHill Biopharma Ltd. ADR (RDHL) Statistics
Valuation metrics
Market Cap 2.32M
Enterprise value -685.29K
Trailing P/E (ttm) -0.35
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 0.54
Price/Book (mrq) 0.3
Enterprise Value/Revenue -0.17
Enterprise Value/EBITDA 0.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 64.38K
Average volume (90 days) 283.18K
Price summary
52-Week low 0.64
52-Week high 3.31
Beta -
50-Day moving average 0.84
200-Day moving average 0.99
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 20 Aug 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.01%
Operating margin -1.07%
Operational effectiveness
Return on assets -0.16%
Return on equity 57.4%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 2.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 0.34%
Book value per share (mrq) 2.37
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
